Related Experiment Videos
[New inhibitors of tumor angiogenesis]
1CNRS EP 560, Institut Pasteur de Lille, France.
Abstract:
During the past few years, our understanding of the molecular mechanisms of angiogenesis has steadily increased. These informations allowed the design of new strategies aimed to kill cancer cells by shutting off the blood vessels through which they get the oxygen and nutrients they need to grow. Therapies that target tumor blood vessels cause the regression of solid tumors in mice. The possibility to obtain synergistic effects by combining antiangiogenic and cytotoxic therapy, and the therapeutic applications of these studies will be discussed, following a meeting on angiogenesis held in Boston on February 10th and 11th 1997.
Insights
New strategies targeting tumor blood vessels, known as antiangiogenic therapy, can inhibit cancer cell growth. Combining antiangiogenic and cytotoxic therapies shows promise for synergistic effects in cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Significant advancements in understanding the molecular mechanisms of angiogenesis.
- Angiogenesis is crucial for supplying tumors with oxygen and nutrients.
Framework:
- Development of novel antiangiogenic strategies targeting tumor vasculature.
- Exploiting the dependence of cancer cells on blood supply for growth and survival.
Implementation:
- Therapies designed to inhibit angiogenesis have demonstrated efficacy in causing solid tumor regression in preclinical models (mice).
Implications:
- Potential for synergistic therapeutic effects by combining antiangiogenic and cytotoxic treatments.
- Exploration of therapeutic applications arising from these antiangiogenesis studies.